Uni-pharma is the only Greek pharmaceutical industry to participate in the PRIX GALIEN 2019 global pharmaceutical prestigious prize.

The Greek pharmaceutical industry participated in the "Best Pharmaceutical Product" category, with TREBON GRIPE day & night.

 

TREBON-GRIPPE® day & night (now in the DISY list) is a dynamic and innovative formula, targeted at colds and flu-like infections. It is an innovative drug with 5-fold action, consisting of a combination of active substances in the form of effervescent tablets.

TREBON-GRIPPE® day & night is available in the form of effervescent tablets with a different formulation for use during the day ("TREBON-GRIPPE® day": 500 mg paracetamol, 200 mg acetylcysteine ​​and 40 mg pseudoephedrine hydrochloride) and overnight "TREBON-GRIPPE® night": 500 mg paracetamol and 4 mg chlorphenamine).

TREBON-GRIPPE® day & night is indicated for the short-term treatment of colds and flu-like infections associated with the formation of mucus viscosity in the respiratory system and accompanied by fever, joint pain and stuffy nose.

Following the legacy of a historic drug of TREBON, the 2nd generation of scientists and the R & D division of the Uni-pharma pharmaceutical industry went one step further, creating Trebon Grippe day & night to cover the patient during afternoons and evenings hours. Thus, with TREBON GRIPPE day & night, the patient is even more strengthened as the formulation also contains the antipyretic and analgesic active substance paracetamol and chlorphenamine maleate, which soothes cough, favors sleep and at the same time also has anti- allergic action.

 

The innovation of TREBON GRIPPE day & night

The innovation of TREBON-GRIPPE® day & night is based on a combination of active ingredients, able to meet the different therapeutic needs of the patient arising during the day and night.

The strategic choice of UNI-PHARMA PHARMACEUTICAL LABORATORIES SA for the creation of TREBON-GRIPPE® day & night was aimed not only at the complete treatment of patients from the unpleasant symptoms of cold without taking multiple formulations, but also in significantly improving the compliance of patients.